Reporting owner · Q3 2026 · CIK 1385155

Meeker David P: insider trades.

Meeker David P reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($5.1M), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
5
Companies
1
Name as filed
Meeker David P

Companies

CompanyRelationshipTransactions
Rhythm Pharmaceuticals, Inc. (RYTM)Director, Officer · President and CEO6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-14Rhythm Pharmaceuticals, Inc.S2,300$105.19239,258Form 4
2026-09-14Rhythm Pharmaceuticals, Inc.S6,439$101.75282,819Form 4
2026-09-14Rhythm Pharmaceuticals, Inc.S30,746$102.35252,073Form 4
2026-09-14Rhythm Pharmaceuticals, Inc.S8,698$103.43243,375Form 4
2026-09-14Rhythm Pharmaceuticals, Inc.S1,817$104.55241,558Form 4
2026-09-14Rhythm Pharmaceuticals, Inc.M50,000$6.05289,258Form 4

Questions

What stock did Meeker David P buy or sell?

Meeker David P reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($5.1M), across 1 company.

Is Meeker David P the same person as other filers with this name?

This page covers SEC CIK 1385155 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/meeker-david-p-1385155.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.